First Manhattan’s Asensus Surgical, Inc. ASXC Stock Holding History

First Manhattan’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-269	Closed	-$4K	–	1416
2019 Q2	$4K	Hold	269	–	–	﹤0.01%	1269
2019 Q1	$8K	Hold	269	–	–	﹤0.01%	1224
2018 Q4	$7K	Hold	269	–	–	﹤0.01%	1213
2018 Q3	$20K	Buy	+269	New	+$18.2K	﹤0.01%	1127

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

First Manhattan's ASXC Position: Q3 2019 in Review

First Manhattan sold out of Asensus Surgical, Inc. (ASXC) in Q3 2019, closing a stake of 269 shares — an estimated $4K sold.

First Manhattan first reported a position in ASXC in Q3 2018 and held it in 4 quarters. The position peaked at $20K in Q3 2018. 130 funds tracked by Wall St. Rank hold ASXC as of Q3 2019.

First Manhattan reported no remaining Asensus Surgical, Inc. position as of Q3 2019 after selling out during the quarter.
First Manhattan sold 269 Asensus Surgical, Inc. shares in Q3 2019, an estimated $4K.
First Manhattan first reported a position in Asensus Surgical, Inc. in Q3 2018 and held it in 4 quarters.
First Manhattan's Asensus Surgical, Inc. position peaked at $20K in Q3 2018.
130 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2019.

Based on First Manhattan's 13F filing for Q3 2019, filed 13 Nov 2019.